Related Experiment Video
Updated: Jun 4, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Transsphenoidal pseudocapsule-based extracapsular resection for pituitary adenomas
Xin Qu1, Jun Yang, Ji-Dong Sun
1Department of Neurosurgery, Provincial Hospital affiliated to Shandong University, Jinan, People's Republic of China.
Acta Neurochirurgica
|February 22, 2011
Summary
Transsphenoidal extracapsular resection using the pseudocapsule for pituitary adenomas offers higher tumor removal and remission rates. This approach is safer and more effective than intracapsular resection, with a significantly lower recurrence rate.
Area of Science:
- Neurosurgery
- Endocrinology
- Oncology
Background:
- Increasing focus on the pseudocapsule's utility in transsphenoidal surgery for pituitary adenomas.
- Prior studies emphasized pseudocapsule histology and surgical technique over therapeutic effectiveness.
- This study evaluates the therapeutic effectiveness of pseudocapsule-based extracapsular resection for pituitary adenomas.
Purpose of the Study:
- To evaluate the overall therapeutic effectiveness of transsphenoidal pseudocapsule-based extracapsular resection for pituitary adenomas.
- To compare the outcomes of extracapsular resection (ER) with traditional intracapsular resection (IR).
Main Methods:
- Retrospective study of 78 patients undergoing ER and 64 patients undergoing IR for pituitary adenomas between January 2004 and October 2007.
- Comparison of complete resection rates, remission rates, complication rates, and recurrence rates between the ER and IR groups.
Main Results:
- Complete resection rates were significantly higher in the ER group (90.6% for Hardy type II, 84.6% for Hardy type III) compared to the IR group (65.5% for Hardy type II, 52.6% for Hardy type III) (P < 0.05).
- Remission rates were also significantly higher in the ER group for both Hardy types II and III (P < 0.05).
- The recurrence rate in the ER group (2.56%) was significantly lower than in the IR group (14.06%), with no significant difference in complication rates (29.5% vs. 26.6%).
Conclusions:
- Transsphenoidal pseudocapsule-based extracapsular resection is a more effective and safe alternative for pituitary adenoma treatment.
- This approach achieves higher tumor removal and remission rates compared to traditional intracapsular resection.
- The ER approach demonstrates a lower recurrence rate, improving long-term patient outcomes.
